AI-generated summary
The Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments report clinical guidelines for treating depressive disorders, drawing on a Medline literature search and expert review. The authors report significant evidence supporting several antidepressant classes and some somatic treatments, including electroconvulsive therapy and light therapy, for some patients with major depressive disorder. Evidence for medications targeting subtypes of the disorder is described as limited.
- Who or what was studied
- Patients with depressive disorders, including major depressive disorder
- Limits stated in the abstract
- The abstract states that evidence for specific medications in depression subtypes is limited and that evidence for augmentation and combination strategies is emerging.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Peer review, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.